Evidence map›Paper›PMID 36533240›Full record

ArticleFrontiers in pediatrics2022

Case report: Compound heterozygosity in

Minsun Kim, Seung Yeob Lee, Namsu Kim, Jaehyeon Lee, Dal Sik Kim, Joonhong Park, Yong Gon Cho

Open access · goldAbstract readCase Reports
In one paragraph

Article in Frontiers in pediatrics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. From Mutation to Manifestation: Evaluation of aAnimals : an open access journal from MDPI · 2025
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Minsun KimDepartment of Pediatrics, Jeonbuk National University Medical School and Hospital, Jeonju, South Korea.
Seung Yeob LeeDepartment of Laboratory Medicine, Jeonbuk National University Medical School and Hospital, Jeonju, South Korea.
Namsu KimDepartment of Laboratory Medicine, Jeonbuk National University Medical School and Hospital, Jeonju, South Korea.
Jaehyeon LeeDepartment of Laboratory Medicine, Jeonbuk National University Medical School and Hospital, Jeonju, South Korea.
Dal Sik KimDepartment of Laboratory Medicine, Jeonbuk National University Medical School and Hospital, Jeonju, South Korea.
Joonhong ParkDepartment of Laboratory Medicine, Jeonbuk National University Medical School and Hospital, Jeonju, South Korea.
Yong Gon ChoDepartment of Laboratory Medicine, Jeonbuk National University Medical School and Hospital, Jeonju, South Korea.
Jeonbuk National University Hospital · KRJeonbuk National University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Red cell pyruvate kinase (PK) deficiency is the most common cause of hereditary nonspherocytic hemolytic anemia and the most frequent enzyme abnormality of the glycolytic pathway. To the best of our knowledge, this is the first Korean PK deficiency study that analyzes copy number variation (CNV) using next-generation sequencing (NGS). A 7-year-old girl with jaundice was admitted for evaluation of a persistent hemolytic anemia. The proband appeared chronically ill, showing a yellowish skin color, icteric sclera, hepatomegaly, and splenomegaly on physical examination. Sequence variants and CNV generated from NGS data were estimated to determine if there was a potential genetic cause. As a result, compound heterozygosity in the

Indexed as

copy number variationmultiplex ligation-dependent probe amplificationnext-generation sequencingp.Gly536AspPK enzyme activityPKLR exon deletionpyruvate kinase deficiency

Identifiers

PMID36533240
PMCPMC9752143
OpenAlexW4311065926

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.